Fibroblast shifts in the hypertensive heart: How single cell RNA-sequencing will accelerate advancements in anti-fibrotic therapies

Alexandra M. Garvin; Taben M. Hale

doi:10.1016/j.yjmcc.2020.11.001

Fibroblast shifts in the hypertensive heart: How single cell RNA-sequencing will accelerate advancements in anti-fibrotic therapies

Alexandra M. Garvin, Taben M. Hale

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	44-45
Number of pages	2
Journal	Journal of Molecular and Cellular Cardiology
Volume	151
DOIs	https://doi.org/10.1016/j.yjmcc.2020.11.001
State	Published - Feb 2021

ASJC Scopus subject areas

Molecular Biology
Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.yjmcc.2020.11.001

Cite this

@article{61bf30cee5e64bf6940326110c7161b2,

title = "Fibroblast shifts in the hypertensive heart: How single cell RNA-sequencing will accelerate advancements in anti-fibrotic therapies",

author = "Garvin, {Alexandra M.} and Hale, {Taben M.}",

note = "Funding Information: The authors thank the National Institutes of HealthNHLBI HL141165 (TMH); and the American Heart Association19AIREA34460000 (TMH) and 19POST34410055 (AMG) for research funding. Funding Information: The authors thank the National Institutes of Health NHLBI HL141165 (TMH) ; and the American Heart Association 19AIREA34460000 (TMH) and 19POST34410055 (AMG) for research funding.",

year = "2021",

month = feb,

doi = "10.1016/j.yjmcc.2020.11.001",

language = "English (US)",

volume = "151",

pages = "44--45",

journal = "Journal of Molecular and Cellular Cardiology",

issn = "0022-2828",

publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Fibroblast shifts in the hypertensive heart

T2 - How single cell RNA-sequencing will accelerate advancements in anti-fibrotic therapies

AU - Garvin, Alexandra M.

AU - Hale, Taben M.

N1 - Funding Information: The authors thank the National Institutes of HealthNHLBI HL141165 (TMH); and the American Heart Association19AIREA34460000 (TMH) and 19POST34410055 (AMG) for research funding. Funding Information: The authors thank the National Institutes of Health NHLBI HL141165 (TMH) ; and the American Heart Association 19AIREA34460000 (TMH) and 19POST34410055 (AMG) for research funding.

PY - 2021/2

Y1 - 2021/2

UR - http://www.scopus.com/inward/record.url?scp=85096192712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85096192712&partnerID=8YFLogxK

U2 - 10.1016/j.yjmcc.2020.11.001

DO - 10.1016/j.yjmcc.2020.11.001

M3 - Letter

C2 - 33181125

AN - SCOPUS:85096192712

SN - 0022-2828

VL - 151

SP - 44

EP - 45

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

ER -

Fibroblast shifts in the hypertensive heart: How single cell RNA-sequencing will accelerate advancements in anti-fibrotic therapies

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this